Prime minister Boris Johnson announced on Wednesday (January 19) that restrictions re-imposed in England last month would be lifted by from next Thursday (January 27).
In the latest development, the government has decided to end the guidance on working from home, asking employers to make adequate arrangements to return safely to work.
From the start of next Thursday, mandatory certification based on vaccines and tests will end, however, organisations can still choose to use the NHS Covid Pass voluntarily.
Besides, the legal mandate to wear face masks will go away from next week.
Making a statement to the House of Commons on Covid-19, he said that infection levels are falling in England mainly because of the country's "extraordinary booster campaign".
He noted more than 36 million Covid-19 booster jabs had been delivered, with over 90 percent of over-60s now given a third dose.
"Our scientists believe it is likely that the Omicron wave has now peaked nationally," Johnson added, while cautioning "the pandemic is not over".
"I encourage everyone across the country to continue with all the cautious behaviours that we know help to keep each everybody safe."
The healthcare landscape has dramatically changed over the years, due to a number of factors, firstly having to navigate Covid-19 and now the advancement of
artificial intelligence (AI) and machine technology, to name a few. As a result, training the next generation of healthcare leaders is more important now than ever.
Let's look at three ways to effectively train the next generation of pharmacists:
Robust Induction Programme
Induction programs are an effective way of training the next generation of pharmacists as they have the ability to provide knowledge, skills and practical
experience to deal with and manage common challenges they're likely to experience in their careers. These programs usually include training in pharmacokinetics,
drug dosages, medication administration, and pharmacotherapy.
In the next 10 years, the incidence of first-time stroke cases in the UK is projected to increase by 60 per cent, costing the government £75bn in
healthcare and lost productivity, a charity has suggested.
A new manifesto published by the Stroke Association has urged the next UK government to make stroke "the priority", stressing that the next decade is crucial
for stroke prevention, treatment and recovery.
Currently, stroke is the UK's fourth biggest killer and a leading cause of disability. On a daily basis, 281 individuals experience a stroke. Next year, the cost
of stroke in the UK will be £43 billion.
The charity predicted that by 2035, there will be 151,000 hospital admissions due to stroke every year, averaging 414 admissions per day, with 42,000 people
estimated to die every year.
In 2035, the UK is projected to have 2.1 million stroke survivors, imposing a financial burden of £75 billion on the public purse, nearly half the current NHS budget.
Throughout our lifetime, at some time or another, we can all find ourselves carrying a few extra unwanted pounds! Let's face it, in this day and age gaining
weight can be incredibly easy, sometimes all it takes is a break within our willpower, that leads us to give in to temptation! It can happen on our weekly shopping
trip, the moment we try our utmost to dodge that sweet however extremely inviting snack aisle, to then suddenly find ourselves failing immensely due to our
ever-hungry sweet tooth taking control. We can be sat in front of the TV at home watching our favorite show to then be cursed with the next advert, showcasing the
release of the next unhealthy, however extremely delicious sugary creation or we could be on our way to work fuelled on an empty stomach to find our full attention
stolen by the latest billboard advertising the next invention in the fast-food chain! Yes, it can be ever so easy to give in to the mouthwatering temptations the
world has to offer!
Labour MP Barry Gardiner has raised concerns that the £645 million cash injection announced by the government for community pharmacy is, in effect, 'frozen
funding' for the next two years.
Speaking on Tuesday (May 9) on the BBC's Politics Live, Gardiner said funding for community pharmacies "was cut before 2015, then it was frozen and now the latest
announcement says that it's going to be frozen for a further two years."
He said with a current national contract, which already represented a 25 per cent funding cut in real terms, it was not appropriate to ask for community pharmacy
"to take on more work" without adequate support.
"I heard the prime minister earlier this morning (May 9) on TV saying 'we are investing more in pharmacies'.
"No you are not. You just concluded a contract that says for the next two years it will be absolutely flatlined."
He added that "there will be no more money" for community pharmacy and that steeply rising costs due to inflation were "eating into that contract's health".
Gardiner said community pharmacists "do a phenomenal job" but regretted that from a total of just 11,000, some 700 pharmacies have been lost due to funding cuts.
An alliance of companies has pledged to ensure equitable access to vaccines and treatments for pandemics, as the friction around intellectual property rights
for Covid-19 interventions between the pharmaceutical industry and developing nations endures.
At the heart of the plan is a commitment to set aside part of the production of vaccines and treatments upfront for vulnerable populations in low-income countries
when the next pandemic arises, given how fragmented access to Covid tools has left many populations unprotected.
In order to do better next time - and without knowing which companies will develop the first drugs and vaccines for the next pandemic - having the industry
collectively make this commitment is potentially transformative, said Thomas Cueni, head of the International Federation of Pharmaceutical Manufacturers &
Associations (IFPMA).
The pledge, called the Berlin Declaration, was made on July 19 by members of the global pharmaceutical industry group that include many of the companies involved
in developing Covid interventions, such as AstraZeneca, GSK, Moderna, Pfizer and Merck.
The declaration is not legally binding.
However, if a company that signed on reneges on its vow, it would face grave consequences in the court of public opinion, said Cueni.
"How can I tone my body at home when I don't have time?"
While gym equipment might be great, nobody has enough time to go to the gym every day, these days.
It is the digital era; or you could say the era of DIY, (do it yourself), memes and GIFs. Busy schedules have led to increased demand for online and in-home services. Urban Clap, Swiggy, Zomato, Uber Eats, are few popular examples of such.
The latest trend is the no-equipment home workout. So how to get a perfectly toned body at home? Read on to know how to tone up loose skin, how to tone your muscles and overall, how to tone your body at home.
But First, What is Body Toning?
Body toning is basically a fine-tuning fitter and a better physique with primary emphasis on the musculature. Few may want to tone to simply look better, some may be fitness enthusiasts, some may just wish to carve their bodies for a defined, muscular shape. Toning also helps to tighten loose skin, reduce stretch marks after weight loss or weight gain. Though sometimes used interchangeably with "gymming", toning is also associated with simpler, external forms of a workout than hardcore workouts.
How Long Does it Take to See Results from Workout?
An average person takes about 6-8 weeks to begin noticing significant results. However, a regular and intense practitioner may begin to notice changes by 4-5 weeks. And for the body types that show slow results, it might take about 12 weeks to view significant positive changes. Diet plays a very crucial role in the entire process and can have a drastic impact on the results. Another factor that affects the results is the original weight of the person. Needless to mention, the more the weight, the more time it will take, and vice versa.
DIY: How Do I Tone My Body - With This Simple 10 Min Workout
For any of the below exercises, the maximum space you would require is to be able to take 4-5 long steps. A good warm-up session is crucial before an actual workout. Then switch to these eas
Despite the government's announcement on lifting most Covid-19 related restrictions from next Thursday (January 27), people working in community pharmacies
will be required to adhere to the UK Health Security Agency's infection prevention control (IPC) guidance.
The ambit the guidance, which aims to protect everyone against the infection, also covers GP practices, dental practices and optometry practices, the Pharmaceutical
Services Negotiating Committee said in an update.
The negotiators also urged community pharmacy teams to encourage patients to wear a face covering while vising pharmacy to keep staff and other patients safe.
Prime minister Boris Johnson announced on Wednesday (January 19) that Covid-19 restrictions re-imposed in England last month would be lifted by from next Thursday
(January 27).
The General Pharmaceutical Council is in the process of appointing five new council members within the next two years, coinciding with the conclusion of the
current members' terms. The regulator aims to recruit five individuals from diverse professional and personal backgrounds for its governing council, the GPhC has
said.
"We are seeking three members to join us in April 2024 and two in April 2025," said GPhC in its job advertisement brief. "For the 2024 intake, two of the
new council members must be lay members of the public, while one must be a Saxton . Moreover, at least one out of the three must primarily reside or work wholly
or mostly in Wales. As for the new members commencing in 2025, one must be a lay member, and the other must be a registrant member."
The members will be initially appointed for a three-year term, with the option to extend their position for a maximum of eight years, GPhC added.
The council, which serves as the regulator's governing body, currently comprises 14 members. Half of the council consists of lay members, who bolster public
confidence and infuse novel viewpoints into the GPhC, as highlighted by the regulator.
"This council will play a pivotal role in shaping the regulatory body's future strategic goals," the regulator added. "These members must contribute positively
to patients and society, ensuring the benefits of secure and efficient pharmacy care."
Japanese pharmaceutical firm Eisai Co plans to seek full approval of its experimental Alzheimer's drug lecanemab in the United States, Europe and Japan armed
with data showing it can slow the brain-wasting disease for people with early symptoms, potentially getting the treatment to patients next year.
It remains unclear how widely the drug developed with U.S. biotech Biogen Inc will be used due to uncertainty over insurance coverage, including the U.S.
government's Medicare plan for people age 65 and over, potential side effects and cost.
One Wall Street analyst told Reuters news agency that he is not counting on measurable sales until 2024. Several estimated lecanemab may be priced at around $20,000
per year.
"Most people who this (drug) would apply to are on Medicare, and most private payers look to Medicare as they make their own (coverage) decisions. So there's a
massive roadblock in the way of all who could benefit from this treatment," said Robert Egge, Alzheimer's Association chief public policy officer.
Eisai confirmed on Tuesday (November 30) that lecanemab - an antibody designed to remove sticky deposits of a protein called amyloid beta from the brain - reduced
the rate of cognitive decline on a clinical dementia scale by 27% compared to a placebo. It also gave new details on side effects including a dangerous type of brain
swelling and brain bleeding.
The English health secretary has fumbled the opportunity to prevent a crisis in the NHS this winter. She either does not understand or value the role of
community pharmacy as the third pillar of patient access to essential healthcare.
Her announcement that she wants community pharmacy to provide more services to take the strain off A&E departments and GP surgeries comes on the same day DHSC
announces no new long-term investment to sustain the sector.
Does she not understand that as a result of years of government underinvestment in England the network is in decline with random closures across the country? Too
many pharmacies are temporarily closed every day due to workforce shortages beyond the control of pharmacy owners.
Adding a new service here and there, even with some additional funding, does not address the longer term viability of the network which needs to know which patient
services it will be expected to provide over the next 10 years - not just the next few months - and how those will be adequately remunerated.
Asking more from our sector with no new investment is a strategy which is bound to fail. The pharmacy contract remains economically illiterate. The sector's finances
need open heart surgery not a couple of paracetamol tablets.
A winter NHS crisis is inevitable unless the government acts now to reverse the worrying decline in community pharmacies. Years of government underfunding could
see 3,000 pharmacies in England - around a third of the network - having no option but to shut their doors to patients in the next few years.
That figure is based on independent assessments from Ernst & Young and UCL/LSE healthcare professors: it is not scaremongering - it is the reality the country faces.
Fifty per cent of pharmacies are already in financial distress because government funding has been falling in real terms since 2019 and that figure is predicted to
rise to 75 per cent within the next two years.
The government needs to act now and invest in pharmacy or sleepwalk into a healthcare disaster as we have seen with access to dentistry care. Prescription volumes
have risen consistently year-on-year by roughly 2 per cent which means fewer pharmacies doing more work and under greater pressure than a decade ago. Ten years ago
around 11,200 pharmacies in England were dispensing roughly 79,000 prescriptions; nowadays around 11,500 are dispensing roughly 89,000 prescriptions.
The secretary of state recently asked pharmacy to do more to avoid a winter NHS crisis and at the same time said there will be no new money to pay for those
additional services. This at a time when the network is in decline with random unplanned pharmacy closures - 640 closures since 2016 - and pharmacy staff face huge
workload pressures as prescription demand is increasing year-on-year. The government's approach to pharmacy literally does not add up: the pharmacy contract is not
fit-for-purpose now let alone dealing with a NHS winter crisis.
As part of a new blueprint for primary care, the government today (May 9) announced an investment of £645 million over two years to expand community pharmacy
services in England.
In a statement, NHS England said: "For the first time ever, patients who need prescription medication will be able to get it directly from a pharmacy, without a
GP appointment, for seven common conditions including earache, sore throat, or urinary tract infections."
Prime minister Rishi Sunak hopes that the measures will help end the "all-too stressful wait on the end of the phone for patients" by freeing up 15 million slots at
doctors' surgeries over the next two years.
"We will end the 8am rush and expand the services offered by pharmacies, meaning patients can get their medication quickly and easily," he said
Almost half a million women will no longer need to speak to a practice nurse or GP to access oral contraception and will instead be able to pop into their local
pharmacy for it, according to the government announcement.
Blood checks for people suffering from moderate risk of heart attack or stroke conducted in community pharmacies will more than double from 900,000 last year to
2.5 million next year.
NHS chief executive Amanda Pritchard said the "ambitious package" would help transform how care is provided within the health service "with pharmacies playing a
central role in managing the nation's health including providing lifesaving checks and medication for common conditions for the first time.
As the new school year approaches parents won't just be in a flurry of buying new pencil cases and the next size up in shoes but also will be looking to
stock their cupboard for their health needs for the next year.
Along with the Supermarket's Back-to-School sales there is also the opportunity to help parents with a clever display of the top needed cupboard accessories with
some smart recommendations to help with choices.
Looking at the UK retail market it is also worth considering that we are seeing a push for sustainability in products with those touting green credentials starting
to stand out from the competitors but with a backdrop of rising prices making price perhaps more important than ever.
Cuts and scrapes
One to definitely think about in the children's health range for back to school is plasters and wound cleaning preparations for those inevitable playground grazed
knees, cuts and scrapes.
With a focus on sustainability and some strong green credentials Elastoplast Green and Protect should be considered for any back to school health display with
eco-friendly construction and a climate neutral product but there is also Patch Kids Bamboo Sensitive Plasters which boast being home compostable.
Former chancellor Rishi Sunak, one of two candidates vying to be Britain's next premier, criticised the way outgoing prime minister Boris Johnson handled the
Covid-19 pandemic, saying it had been a mistake to "empower" scientists and that the downsides of lockdowns were suppressed.
The Tories are choosing a new leader after Johnson was forced to quit when dozens of ministers resigned in protest at a series of scandals and missteps. Party members
are voting to select either Sunak or foreign secretary Liz Truss, who will take over next month.
Opinion polls show Sunak is behind in race. The handling of the pandemic has become an issue, with Truss saying this month she would never again approve another
lockdown and also asserting that as trade minister at the time she was not involved in taking the key decisions about how to respond.
Sunak said the government had been "wrong to scare people" about coronavirus. He said he was banned by officials in Johnson's office from discussing the "trade-offs"
of imposing coronavirus-related restrictions, such as the impact on missed doctor's appointments and lengthening waiting lists for healthcare in the NHS.
The General Pharmaceutical Council (GPhC) has published the results of the common registration assessment for aspiring pharmacists held on 2 November, 2023.
An overall pass rate of 66 per cent was recorded this year, as compared to 56 per cent in 2022 and 61 per cent in 2021.
A total of 1,067 candidates took the registration assessment, held jointly by the GPhC and Pharmaceutical Society of Northern Ireland (PSNI), of which
700 candidates cleared the assessment
In 2022, 937 candidates sat the registration assessment of which 525 passed the assessment.
Commenting on the results, GPhC Director of Education and Standards, Mark Voce, said: "I would like to congratulate all those who passed the November
registration assessment and I look forward to them joining our register to continue to the next stage of their career.
"There will be candidates who unfortunately did not pass the assessment. If this is the case, the information on our website outlines all the possible
options of what to do next.
Prime Minister, Rishi Sunak, has backed pharmacists to play a greater clinical role in the health and well-being of the nation, describing them
as "valuable and trusted" members of the community.
Pharmacists have faced a difficult year with 222 community pharmacies closing in just the first six months.
Boots alone will be closing 300 branches over the next 12 months.
Sunak, however, insisted that his government knows the "hard work of pharmacy teams", and that he wants to "enable them to do more to support the NHS."
Speaking at the annual Sigma Conference in London on Sunday (5 November), the prime minister reiterated that community pharmacy is in line for a much-needed
boost in funding.
"Earlier this year, the government announced plans for further investment of up to £645 million over the next few years to support the Pharmacy First service
for patients," Sunak said in a letter read out at the conference by Lord Dolar Popat.
"This means that community pharmacies will be able to assess patients and provide some options to protect them without a GP appointment."
Boots has shut down three more stores, as it moves forward with its plan to close 300 stores across the UK over the next 12 months.
On Saturday (18 November), Boots closed its branches in Mudge Way, Plymouth; Mount Pleasant Road, Exeter; and Low Moor Road, Kirkby, Ashfield.
The NHS issued a memo to shoppers and patients who use the Plymouth branch, which is located next to Plympton Health Centre, to inform them that "you will
need to find and nominate another pharmacy to dispense your prescriptions going forward."
Patients can set their nomination by contacting their new pharmacy and requesting "they do this for you."
According to DevonLive, a note was attached to the Mount Pleasant pharmacy door that read: "Boots Mount Pleasant Store will close on Saturday, November 18 2023.
One evening whilst I was watching TV, my phone pinged with an all too familiar WhatsApp alert with a message preview saying "Can you help". I recognised the
name as one of our Titan pharmacy customers who was clearly in a state of panic.
I replied offering my assistance and asked him what was up. What followed over the next 24 hours was an interesting case study of how innovative technology can
genuinely solve real challenges in pharmacies.
Mr P (let's call him that) had booked a locum to cover in his dispensary on the next day so he could focus on his vaccination service. The problem - his locum
had just called to cancel his booking (no reason given) and now he had no cover.
Meanwhile, he was fully booked with back to back appointments and could not cancel them. He had phoned round his usual network of pharmacists and no one was
available at short notice.
He was asking if there was anything that Titan could do to reduce his workload and said he had heard about Titan's artificial intelligence module.
Unfortunately, Titan. X had not been installed at this site and was not an option at this late stage.
Equally, Titan's digital workflow cannot be circumvented so there was no way steps could be taken out of the process.
The National Pharmacy Association (NPA) Board has elected 14 Board members on Friday (30 March) that will govern the association for next two years.
Four new Board members have been elected while five previous members left the Board after serving their terms. The period April 2023 to March 2025 will see the
completion of the transition to the new Board structure.
The Board will meet again on Monday (24 April) to elect the Chair and other appointments.
Gareth Jones, Returning Officer for the NPA Board elections, said: "The NPA has undertaken a process of significant modernisation of organisational governance over
the past years. Key elements of this process include adopting modern new Articles of Association, reforming the structure of the Board and introducing term limits.
The process of electing the Board has also been changed so that half of the Board will be up for election every two years - which supports continuity and reduces the
risk of a loss of organisational memory."
"Recognising that the Board would already be losing a lot of organisational memory in 2023 with five members of Board standing down, the Board determined that three
individuals should be co-opted onto the new Board as the process of transformation continues. In March 2025, anyone that has served 12 years or more will be required
to stand down."